Clinical outcomes three years after PLAATO implantation

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 5, 2007, Pages 704-707

  El Chami, Mikhael F ^a   Grow, Parker ^a   Eilen, Dana ^b   Lerakis, Stamatios ^a   Block, Peter C ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Atrial fibrillation; Left atrial appendage occlusion; Stroke

Indexed keywords

WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DEVICE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MALE; PERCUTANEOUS LEFT ATRIAL APPENDAGE TRANSCATHETER OCCLUSION SYSTEM; RISK FACTOR; SAFETY; SCORING SYSTEM; STROKE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; BALLOON OCCLUSION; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EQUIPMENT SAFETY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GEORGIA; HEART CATHETERIZATION; HUMANS; INCIDENCE; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34147204412     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21026     Document Type: Article

References (14)

1. Falk RH. Atrial fibrillation. N Engl J Med 2001;344:1067-1078.
2. Ostermayer S, Reschke M, Billinger K, Trepels T, Buschek F, Bayard Y, Sievert H. Percutaneous closure of the left atrial appendage. J Interv Cardiol 2003;16:553-556.
3. Porebska A, Nowacki P. Atrial fibrillation as a relevant risk factor for stroke. Neurol Neurochir Pol 2005;39:134-140.
4. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60:417-422.
5. Hanna IR, Kolm P, Martin R, Reisman M, Gray W, Block PC. Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): Six-month echocardiographic follow-up. J Am Coll Cardiol 2004;43:1868-1872.
6. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Delia Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol 2005; 46:9-14.
7. Omran H, Schmidt H, Hardung D, Hammerstingl C, von der Recke G, Haas S, Buttner R, Luderitz B. Post mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation. J Interv Card Electrophysiol 2005;14:17-20.
8. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
9. Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC. The risks of warfarin use in the elderly. Expert Opin Drug Saf 2006;5:417-431.
10. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The stroke prevention in atrial fibrillation investigators. Arch Intern Med 1996;156:409-416.
11. Hylek EM, D'Antonio J, Evans-Molina C, Shea C, Henault LE, Regan S. Translating the results of randomized trials into clinical practice: The challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation. Stroke 2006; 37:1075-1080.
12. Somerfield J, Barber PA, Anderson NE, Kumar A, Spriggs D, Charleston A, Bennett P, Baker Y, Ross L. Not all patients with atrial fibrillation-associated ischemic stroke can be started on anticoagulant therapy. Stroke 2006;37:1217-1220.
13. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P. Selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin. Circulation 2004;110:2287-2292.
14. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-691.